January 6, 2017 / 2:57 AM / 7 months ago

BRIEF-Jiangsu Nhwa Pharmaceutical gets authorization of NVX-408 from NuvOx Pharma, LLC

Jan 6 (Reuters) - Jiangsu Nhwa Pharmaceutical Co., Ltd. :

* Says it signed contract to get the authorization of NVX-408 from NuvOx Pharma, LLC

* Says NVX-408 is for treatment of blood loss and hemorrhagic shock

* Says the co got the right to develop NVX-408 and driving its sales in China mainland

* Says the co will pay $3.6 million in total for the authorization

Source text in Chinese:rrd.me/bgaqW

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below